25 Years of Varicella Vaccination in the United States

被引：14
|
作者：
Marin, Mona [1 ]
Seward, Jane F. [1 ,2 ]
Gershon, Anne A. [3 ]
机构：
[1] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA
[2] ASRT Inc, Smyrna, GA USA
[3] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA
来源：
JOURNAL OF INFECTIOUS DISEASES | 2022年 / 226卷 / SUPP 4期
关键词：
chickenpox; varicella; vaccine; VZV; program; HERPES-ZOSTER; OKA-STRAIN; CHILDREN; EXPERIENCE; HOSPITALIZATIONS; PREVENTION; LICENSURE; PROGRAMS; EFFICACY; EXPOSURE;
D O I：
10.1093/infdis/jiac251
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：S375 / S379
页数：5
相关论文
共 50 条
  • [41] The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States: Comparison of Birth Cohorts Preceding and Following Varicella Vaccination Program Launch
    Leung, Jessica
    Dooling, Kathleen
    Marin, Mona
    Anderson, Tara C.
    Harpaz, Rafael
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (SUPP 4) : S470 - S477
  • [42] Health and Economic Impact of the United States Varicella Vaccination Program, 1996-2020
    Zhou, Fangjun
    Leung, Jessica
    Marin, Mona
    Dooling, Kathleen L.
    Anderson, Tara C.
    Ortega-Sanchez, Ismael R.
    JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (SUPP 4) : S463 - S469
  • [43] The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom
    van Hoek, Albert Jan
    Melegaro, Alessia
    Gay, Nigel
    Bilcke, Joke
    Edmunds, W. John
    VACCINE, 2012, 30 (06) : 1225 - 1234
  • [44] Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England
    van Hoek, Albert Jan
    Melegaro, Alessia
    Zagheni, Emelio
    Edmunds, W. John
    Gay, Nigel
    VACCINE, 2011, 29 (13) : 2411 - 2420
  • [45] Understanding the role of exogenous boosting in modeling varicella vaccination
    Talbird, Sandra E.
    La, Elizabeth M.
    Mauskopf, Josephine
    Altland, Alexandra
    Daniels, Vince
    Wolfson, Lara J.
    EXPERT REVIEW OF VACCINES, 2018, 17 (11) : 1021 - 1035
  • [46] Varicella vaccine effectiveness over 10 years in Australia; moderate protection from 1-dose program
    Quinn, Helen E.
    Gidding, Heather F.
    Marshall, Helen S.
    Booy, Robert
    Elliott, Elizabeth J.
    Richmond, Peter
    Crawford, Nigel
    McIntyrean, Peter B.
    Macartney, Kristine K.
    Blyth, C.
    Britton, P.
    Buttery, J.
    Clark, J. E.
    Connell, J.
    Dale, R.
    Deverell, M.
    Dougherty, S.
    Finucane, C.
    Gibson, M.
    Gold, M.
    Heath, C.
    Hickie, L.
    Hutchinson, T.
    Jones, C.
    Jones, J.
    Kent, J.
    Knight, H.
    Kynaston, A.
    Lee, D.
    Lewis, G.
    Low, S.
    Maclean, N.
    McDonald, F.
    McLaren, N.
    McMinn, A.
    McRae, J.
    Murphy, J.
    Nissen, M.
    Orr, C.
    Orr, K.
    Phillips, N.
    Pym, M.
    Quinn, J.
    Rhind, L.
    Roberts, A.
    Robins, C.
    Rost, L.
    Royle, J.
    Snelling, T.
    Talbott, C.
    JOURNAL OF INFECTION, 2019, 78 (03) : 220 - 225
  • [47] Varicella prevention in the United States: A review of successes and challenges
    Marin, Mona
    Meissner, H. Cody
    Seward, Jane F.
    PEDIATRICS, 2008, 122 (03) : E744 - E751
  • [48] Herpes Zoster Incidence Among Insured Persons in the United States, 1993-2006: Evaluation of Impact of Varicella Vaccination
    Leung, Jessica
    Harpaz, Rafael
    Molinari, Noelle-Angelique
    Jumaan, Aisha
    Zhou, Fangjun
    CLINICAL INFECTIOUS DISEASES, 2011, 52 (03) : 332 - 340
  • [49] Strategies for Pandemic and Seasonal Influenza Vaccination of Schoolchildren in the United States
    Basta, Nicole E.
    Chao, Dennis L.
    Halloran, M. Elizabeth
    Matrajt, Laura
    Longini, Ira M., Jr.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (06) : 679 - 686
  • [50] Global impact of varicella vaccination programs
    Varela, Fernanda Hammes
    Pinto, Leonardo Araujo
    Scotta, Marcelo Comerlato
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (03) : 645 - 657
12345